Multicenter Trial of Immunotherapy With House Dust Mite Allergoid

NCT00540631 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinoconjunctivitis

Interventions

BIOLOGICAL: specific immunotherapy with Acaroid, subcutaneously, Up-titration till strength B 0.6 mL (6000 TU)

Sponsor

Allergopharma GmbH & Co. KG